Author

H. Namkoong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:CITE-seq· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Habtezion· 2 shared B. Lee· 2 shared A. Yoshifuji· 1 shared A. Yoshimura· 1 shared D. Heller· 1 shared D. M. Mikhail· 1 shared G. L. Szot· 1 shared G. Swaminathan· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Habtezion

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant.

S. Mise-Omata, M. Ikeda, M. Takeshita, Y. Uwamino, M. Wakui, T. Arai, A. Yoshifuji, K. Murano, H. Siomi, K. Nakagawara, M. Ohyagi, M. Ando, N. Hasegawa, H. Saya, M. Murata, , A. Yoshimura

bioRxiv · Jul 31, 2022 · PreprintImmunology

Single-cell sequencing unveils distinct immune microenvironment with CCR6-CCL20 crosstalk in human chronic pancreatitis

B. Lee, H. Namkoong, Y. Yang, H. Huang, D. Heller, G. L. Szot, M. M. Davis, S. J. Pandol, M. D. Bellin, A. Habtezion

This study uses single-cell sequencing to identify distinct immune features and CCR6-CCL20 crosstalk in hereditary versus idiopathic chronic pancreatitis.

bioRxiv · Apr 5, 2021Immunology

GPR15 in colon cancer development and anti-tumor immune responses.

H. NamKoong, B. Lee, G. Swaminathan, S.-J. Koh, S. Rogalla, D. M. Mikhail, A. Habtezion

This study investigates the role of GPR15 in colon cancer, showing its deficiency promotes tumor growth by altering immune responses, and identifies GPR15L as a potential therapeutic target.

bioRxiv · Mar 13, 2021Immunology